NIH-funded research NIH-funded research

Effects of therapy and medication on sleep and blood pressure in people with insomnia

Official title: 2/2 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial

Funded at University of Pittsburgh at Pittsburgh · NIH-10873285 · Data updated 2026-11-12

This study is looking at how two treatments—Cognitive Behavioral Therapy for Insomnia (CBT-I) and the medication trazodone—can help improve sleep and lower blood pressure in adults who struggle with insomnia, especially those who don’t get enough sleep. If you have insomnia and want to see if these options could work for you, this research might be a good fit!

More Randomized Controlled Trial research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$435,822
NIH project number5U24HL161359-02
Project IDNIH-10873285 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults aged 18 and older who experience insomnia, particularly those with short sleep duration and elevated blood pressure.

Less likely to help

Patients who do not have insomnia or those with normal sleep duration may not benefit from this research.

What this research studies

This research investigates how Cognitive Behavioral Therapy for Insomnia (CBT-I) and the medication trazodone affect sleep and blood pressure in adults with different types of insomnia. It focuses on individuals with insomnia characterized by short sleep duration, which is linked to higher health risks. The study will involve a cohort of 600 adults, assessing the effectiveness of CBT-I and trazodone through a randomized controlled trial. Participants will be monitored for changes in sleep patterns and blood pressure levels.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment options for insomnia that also help reduce blood pressure and associated health risks.

How similar studies have gone: Previous research has shown promising results for CBT-I and trazodone in treating insomnia, but this specific approach focusing on insomnia phenotypes is relatively novel.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Wisniewski, Stephen R — University of Pittsburgh at Pittsburgh
  • Study coordinator: Wisniewski, Stephen R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.